Cargando…

Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial

BACKGROUND: This first-in-human phase 1 trial is to evaluate the safety, pharmacokinetics, preliminary efficacy, and biomarkers of sugemalimab, a full-length, fully human anti-PD-L1 monoclonal antibody, in Chinese patients with advanced malignancies. METHODS: Eligible patients with unresectable adva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Jifang, Cao, Junning, Zhang, Qingyuan, Xu, Nong, Zhao, Yanqiu, Xing, Baocai, Miao, Zhanhui, Wu, Yilong, Pan, Hongming, Gao, Quanli, Li, Xingya, Liu, Baorui, Li, Wei, Pei, Zhidong, Xia, Hongqiang, Qi, Qinzhou, Dai, Hangjun, Shi, Qingmei, Yang, Jianxin, Li, Jin, Shen, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293819/ https://www.ncbi.nlm.nih.gov/pubmed/34984540 http://dx.doi.org/10.1007/s00262-021-03102-3

Ejemplares similares

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study
por: Huang, Huiqiang, et al.
Publicado: (2023)

Cost-effectiveness analysis of sugemalimab vs. placebo, in combination with chemotherapy, for treatment of first-line metastatic NSCLC in China
por: Li, Wei, et al.
Publicado: (2022)

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China
por: Wang, Hao, et al.
Publicado: (2022)

Sugemalimab plus chemotherapy vs. chemotherapy for metastatic non-small-cell lung cancer: A cost-effectiveness analysis
por: Liang, Xueyan, et al.
Publicado: (2023)

A trial-based cost-utility analysis of sugemalimab vs. placebo as consolidation therapy for unresectable stage III NSCLC in China
por: Li, Wei, et al.
Publicado: (2023)

Cost-effectiveness analysis of sugemalimab vs. chemotherapy as first-line treatment of metastatic nonsquamous non-small cell lung cancer
por: Zheng, Zhiwei, et al.
Publicado: (2022)

Targeting VEGF/VEGFR to Modulate Antitumor Immunity
por: Yang, Ju, et al.
Publicado: (2018)

Making cytology specimens solid materials for testing predictive marker of immunotherapy in NSCLC
por: Wang, Hangjun, et al.
Publicado: (2018)

Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors:  Safety, Efficacy, and Biomarkers
por: Wang, Yakun, et al.
Publicado: (2022)

The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
por: Zhang, Qian, et al.
Publicado: (2021)

Diffusive and martensitic nucleation kinetics in solid-solid transitions of colloidal crystals
por: Peng, Yi, et al.
Publicado: (2017)

Interleukin-24 enhancing antitumor activity of chimeric oncolytic adenovirus for treating acute promyelocytic leukemia cell
por: Liu, Li, et al.
Publicado: (2019)

Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
por: Li, Rutian, et al.
Publicado: (2013)

Phase 1 Study of the Selective c-MET Inhibitor, HS-10241, in Patients With Advanced Solid Tumors
por: Dong, Xiaorong, et al.
Publicado: (2022)

Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway
por: Zhang, Jingyu, et al.
Publicado: (2016)

Analysis of gene co-expression network reveals prognostic significance of CNFN in patients with head and neck cancer
por: Liu, Baoling, et al.
Publicado: (2019)

A rare case of multifocal intraductal nodules and a solid mass of the pancreas
por: Li, Jun, et al.
Publicado: (2021)

Phase I Dose‐Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors
por: Cao, Junning, et al.
Publicado: (2017)

Nano Polymeric Carrier Fabrication Technologies for Advanced Antitumor Therapy
por: Li, Wei, et al.
Publicado: (2013)

GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration
por: Peng, Zhouyangfan, et al.
Publicado: (2020)

DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice
por: Cao, Jun, et al.
Publicado: (2013)

Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors
por: Pesce, Silvia, et al.
Publicado: (2023)

Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis
por: Zhou, Jiupeng, et al.
Publicado: (2022)

The role of PTP1B (PTPN1) in the prognosis of solid tumors: A meta-analysis
por: Zhou, Jiupeng, et al.
Publicado: (2022)

Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor
por: Zhang, Zhiwei, et al.
Publicado: (2019)

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
por: Sun, Yongkun, et al.
Publicado: (2016)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Research Progress on the Regulation of Autophagy and Apoptosis in Insects by Sterol Hormone 20-Hydroxyecdysone
por: Lin, Luobin, et al.
Publicado: (2023)

Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity
por: de Gruil, Nadia, et al.
Publicado: (2022)

A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine
por: Liu, Da, et al.
Publicado: (2019)

Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF-κB signaling pathway
por: Zeng, Anqi, et al.
Publicado: (2021)

Correction: Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor
por: Zhang, Zhiwei, et al.
Publicado: (2020)

Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer
por: Yang, Ju, et al.
Publicado: (2019)

Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer
por: Zhang, Dinghu, et al.
Publicado: (2020)

Recent Advances in Metal–Organic Frameworks Derived Nanocomposites for Photocatalytic Applications in Energy and Environment
por: Hussain, Mian Zahid, et al.
Publicado: (2021)

Pseudoginsengenin DQ Exhibits Therapeutic Effects in Cisplatin-Induced Acute Kidney Injury via Sirt1/NF-κB and Caspase Signaling Pathway without Compromising Its Antitumor Activity in Mice
por: Qi, Zeng, et al.
Publicado: (2018)

Rosmarinic Acid Alleviates the Endothelial Dysfunction Induced by Hydrogen Peroxide in Rat Aortic Rings via Activation of AMPK
por: Zhou, Hui, et al.
Publicado: (2017)

Spirulina platensis Lacks Antitumor Effect against Solid Ehrlich Carcinoma in Female Mice
por: Barakat, Waleed, et al.
Publicado: (2015)

Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect
por: Chen, Enrui, et al.
Publicado: (2020)

Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
por: Bahmani, Baharak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mdbbgsdlfm3uhfr71818peuptt